Mette Kirstine Agger

Insider Reports History

Location
Burlington, MA
Signature
/s/ John H. Tucker, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mette Kirstine Agger:

Company Role Class Num Shares Value Price $ Report Date Ownership
Lexeo Therapeutics, Inc. Director Stock Option (right to buy) 25,000 26 Jun 2025 Direct
scPharmaceuticals Inc. Director Stock Option (Right to Buy) 0 07 Oct 2025 Direct

Insider Reports Filed by Mette Kirstine Agger

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SCPH scPharmaceuticals Inc. 07 Oct 2025 2 $0 4 Director 07 Oct 2025, 16:30
LXEO Lexeo Therapeutics, Inc. 26 Jun 2025 1 $0 4 Director 30 Jun 2025, 17:00
SCPH scPharmaceuticals Inc. 03 Jun 2025 1 $0 4 Director 05 Jun 2025, 17:31
LXEO Lexeo Therapeutics, Inc. 25 Jun 2024 1 $0 4 Director 27 Jun 2024, 17:01
SCPH scPharmaceuticals Inc. 11 Jun 2024 1 $0 4 Director 13 Jun 2024, 17:00
LXEO Lexeo Therapeutics, Inc. 02 Feb 2024 1 $0 4 Director 06 Feb 2024, 17:57
LXEO Lexeo Therapeutics, Inc. 02 Nov 2023 0 $0 3 Director 02 Nov 2023, 21:15
SCPH scPharmaceuticals Inc. 06 Jun 2023 1 $0 4 Director 08 Jun 2023, 16:15